Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse
- PMID: 7883961
- PMCID: PMC441449
- DOI: 10.1172/JCI117760
Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse
Abstract
These studies were undertaken to quantify cholesterol balance across the plasma space and the individual organs of the mouse, and to determine the role of the low density lipoprotein receptor (LDLR) in these two processes. In the normal mouse (129 Sv), sterol was synthesized at the rate of 153 mg/d per kg body weight of which 78% occurred in the extrahepatic tissues while only 22% took place in the liver. These animals metabolized 7.1 pools of LDL-cholesterol (LDL-C) per day, and 79% of this degradation took place in the liver. Of this total turnover, the LDLR accounted for 88% while the remaining 12% was receptor independent. 91% of the receptor-dependent transport identified in these animals was located in the liver while only 38% of the receptor-independent uptake wsa found in this organ. When the LDLR was deleted, the LDL-C production rate increased 1.7-fold, LDL-C turnover decreased from 7.1 to 0.88 pools/d, and the plasma LDL-C level increased 14-fold, from 7 to 101 mg/dl. Despite these major changes in the circulating levels of LDL-C, however, there was no change in the rate of cholesterol synthesis in any extrahepatic organ or in the whole animal, and, further, there was no change in the steady-state cholesterol concentration in any organ. Thus, most extrahepatic tissues synthesize their daily sterol requirements while most LDL-C is returned directly to the liver. Changes in LDLR activity, therefore, profoundly alter the plasma LDL-C concentration but have virtually no affect on cholesterol balance across any extrahepatic organ, including the brain.
Similar articles
-
Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences.J Clin Invest. 1985 Sep;76(3):1113-22. doi: 10.1172/JCI112066. J Clin Invest. 1985. PMID: 2995447 Free PMC article.
-
Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse.Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12500-4. doi: 10.1073/pnas.92.26.12500. Proc Natl Acad Sci U S A. 1995. PMID: 8618929 Free PMC article.
-
Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit.J Lipid Res. 1987 Jan;28(1):32-41. J Lipid Res. 1987. PMID: 3559399
-
Regulation of cholesterol metabolism in man and in other species.Klin Wochenschr. 1984 Apr 16;62(8):338-45. doi: 10.1007/BF01716251. Klin Wochenschr. 1984. PMID: 6328101 Review.
-
Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism.Immunol Today. 1999 Aug;20(8):362-6. doi: 10.1016/s0167-5699(99)01496-6. Immunol Today. 1999. PMID: 10431156 Review.
Cited by
-
Effect of dietary cholesterol on low density lipoprotein-receptor, 3-hydroxy-3-methylglutaryl-CoA reductase, and low density lipoprotein receptor-related protein mRNA expression in healthy humans.Lipids. 1998 Dec;33(12):1177-86. doi: 10.1007/s11745-998-0321-8. Lipids. 1998. PMID: 9930403
-
The Niemann-Pick C1 and caveolin-1 proteins interact to modulate efflux of low density lipoprotein-derived cholesterol from late endocytic compartments.J Mol Biochem. 2014 Feb 28;3(1):14-26. J Mol Biochem. 2014. PMID: 25285302 Free PMC article.
-
Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte.J Biomed Res. 2017 Jan 19;31(2):95-107. doi: 10.7555/JBR.31.20160139. J Biomed Res. 2017. PMID: 28808191 Free PMC article.
-
Aberrant oligodendroglial LDL receptor orchestrates demyelination in chronic cerebral ischemia.J Clin Invest. 2021 Jan 4;131(1):e128114. doi: 10.1172/JCI128114. J Clin Invest. 2021. PMID: 33141760 Free PMC article.
-
Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma.Cancers (Basel). 2019 Jan 26;11(2):146. doi: 10.3390/cancers11020146. Cancers (Basel). 2019. PMID: 30691162 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases